Steffen Hirsch

1.1k total citations
17 papers, 394 citations indexed

About

Steffen Hirsch is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Steffen Hirsch has authored 17 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Steffen Hirsch's work include Cancer Genomics and Diagnostics (4 papers), Glioma Diagnosis and Treatment (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). Steffen Hirsch is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Glioma Diagnosis and Treatment (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). Steffen Hirsch collaborates with scholars based in Germany, United Kingdom and United States. Steffen Hirsch's co-authors include Thomas Ludwig, Reena Shakya, Matthias Szabolcs, Francesca Cole, Maria Jasin, James Hicks, Chyuan-Sheng Lin, Kandasamy Ravi, Dieter Egli and Colleen R. Reczek and has published in prestigious journals such as Science, Cancer Research and International Journal of Cancer.

In The Last Decade

Steffen Hirsch

15 papers receiving 385 citations

Peers

Steffen Hirsch

ONCOL

GENET

PFM

Çiğdem Himmetoğlu Türkiye

Kristiina Aittomäki Finland

R Egido Spain

Dariusz Samulak Poland

Irini Xilouri Greece

Saulius Girnius United States

María Jesús García Villanueva Spain

Albert Pérez-Ladaga Spain

Moonjoo Han United States

Friederike Schneider Germany

Çiğdem Himmetoğlu Türkiye

Steffen Hirsch

163 ×0.6

109 ×0.8

ONCOL

143 ×1.2

GENET

35 ×0.9

34 ×1.0

PFM

Citations per year, relative to Steffen Hirsch Steffen Hirsch (= 1×) peers Çiğdem Himmetoğlu

Countries citing papers authored by Steffen Hirsch

Since Specialization

Citations

This map shows the geographic impact of Steffen Hirsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Hirsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Hirsch more than expected).

Fields of papers citing papers by Steffen Hirsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen Hirsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Hirsch. The network helps show where Steffen Hirsch may publish in the future.

Co-authorship network of co-authors of Steffen Hirsch

This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Hirsch. A scholar is included among the top collaborators of Steffen Hirsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Hirsch. Steffen Hirsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Hirsch, Steffen, Lennart Kester, Mariëtte E.G. Kranendonk, et al.. (2024). Molecular analysis of cancer genomes in children with Lynch syndrome: Exploring causal associations. International Journal of Cancer. 154(8). 1455–1463. 4 indexed citations

Blattner-Johnson, Mirjam, Dominik Sturm, Steffen Hirsch, et al.. (2024). HGG-21. DISTRIBUTION AND MUTATIONAL PATTERNS OF TP53 ALTERATIONS ACROSS SUBTYPES OF PEDIATRIC HIGH-GRADE GLIOMAS. Neuro-Oncology. 26(Supplement_4). 0–0.

Brennenstuhl, Heiko, et al.. (2024). Hao‐Fountain syndrome: 32 novel patients reveal new insights into the clinical spectrum. Clinical Genetics. 105(5). 499–509. 10 indexed citations

Sutter, Christian, et al.. (2023). BRCA1/2 potential founder variants in the Jordanian population: an opportunity for a customized screening panel. Hereditary Cancer in Clinical Practice. 21(1). 11–11. 2 indexed citations

Schweizer, Leonille, Wolfgang Hartmann, Arend Koch, et al.. (2022). Evidence of neural crest cell origin of a DICER1 mutant CNS sarcoma in a child with DICER1 syndrome and NRAS‐mutant neurocutaneous melanosis. Neuropathology and Applied Neurobiology. 48(6). e12830–e12830. 6 indexed citations

Frühwald, Michael C., Karolina Nemes, Heidrun Boztug, et al.. (2021). Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group. Familial Cancer. 20(4). 305–316. 25 indexed citations

Guerrini‐Rousseau, Léa, Miriam J. Smith, Christian P. Kratz, et al.. (2021). Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG). Familial Cancer. 20(4). 317–325. 17 indexed citations

Thieme, Anne, Katja Maurus, Karen Ernestus, et al.. (2021). Secondary Biphenotypic Acute Leukemia Following Rosai-Dorfman-Disease A Coincidence?. Klinische Pädiatrie. 234(3). 169–171.

Hirsch, Steffen, Nicola Dikow, Stefan M. Pfister, & Kristian W. Pajtler. (2021). Cancer predisposition in pediatric neuro-oncology—practical approaches and ethical considerations. Neuro-Oncology Practice. 8(5). 526–538. 5 indexed citations

10.

Bolkestein, Michiel, John Wong, Verena Thewes, et al.. (2020). Chromothripsis in Human Breast Cancer. Cancer Research. 80(22). 4918–4931. 17 indexed citations

11.

Hirsch, Steffen, Laura Gieldon, Christian Sutter, Nicola Dikow, & Christian P. Schaaf. (2020). Germline testing for homologous recombination repair genes—opportunities and challenges. Genes Chromosomes and Cancer. 60(5). 332–343. 3 indexed citations

12.

Carceller, Fernando, Steffen Hirsch, Komel Khabra, et al.. (2019). High-dose etoposide and cyclophosphamide in adults and children with primary refractory and multiply relapsed acute leukaemias: The Royal Marsden experience. Leukemia Research. 85. 106217–106217. 4 indexed citations

13.

Sturm, Dominik, Felix Sahm, Felipe Andreiuolo, et al.. (2019). GENE-08. THE MNP 2.0 STUDY: PROSPECTIVE INTEGRATION OF DNA METHYLATION PROFILING IN CNS TUMOR DIAGNOSTICS. Neuro-Oncology. 21(Supplement_2). ii82–ii82. 2 indexed citations

14.

Hirsch, Steffen, et al.. (2015). Targeted approaches to childhood cancer: progress in drug discovery and development. Expert Opinion on Drug Discovery. 10(5). 483–495. 3 indexed citations

15.

Shakya, Reena, Tamas A. Gonda, Michael Quante, et al.. (2012). Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma. Cancer Research. 73(2). 885–896. 62 indexed citations

16.

Shakya, Reena, Colleen R. Reczek, Francesca Cole, et al.. (2011). BRCA1 Tumor Suppression Depends on BRCT Phosphoprotein Binding, But Not Its E3 Ligase Activity. Science. 334(6055). 525–528. 180 indexed citations

17.

Kashif, Waqar, et al.. (2003). Proteinuria: how to evaluate an important finding.. Cleveland Clinic Journal of Medicine. 70(6). 535–537. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact